报价延迟最少15分钟:2025/11/20 08:48 EST
盘前时段
|
||||
|
72.98 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
--
|
|
|
| 价值评估 |
|
盈利(现时/预测)
4.83/4.70
|
|
企业价值
40.70B
|
| 资产负债 |
|
每股账面净值
21.94
|
| 现金流量 |
|
现金流量率
0.06
|
| 损益表 |
|
收益
19.67B
|
|
每股收益
42.85
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/11/20 08:48 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%). |
